LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,293 | 6,411 | 1,872 | 3,976 | 3,673 |
| Marketable Securities | 63,936 | 66,466 | 13,818 | 17,816 | 26,530 |
| TOTAL | $66,785 | $73,780 | $16,466 | $22,717 | $30,498 |
| Non-Current Assets | |||||
| PPE Net | 3,668 | 4,037 | 4,519 | 4,992 | 5,467 |
| Intangibles | 3,199 | 3,111 | 3,105 | 3,247 | 3,487 |
| TOTAL | $6,867 | $7,148 | $7,624 | $8,239 | $8,954 |
| Total Assets | $73,652 | $80,928 | $24,090 | $30,956 | $39,452 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,236 | 866 | 489 | 647 | 618 |
| Accrued Expenses | 3,992 | 2,289 | 2,231 | 2,559 | 4,664 |
| TOTAL | $5,582 | $3,656 | $3,366 | $3,999 | $6,172 |
| Non-Current Liabilities | |||||
| Long Term Debt | 85 | 142 | 228 | 335 | 496 |
| TOTAL | $85 | $142 | $228 | $335 | $496 |
| Total Liabilities | $5,667 | $3,798 | $3,594 | $4,334 | $6,668 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,577 | 32,535 | 74,153 | 74,039 | 73,902 |
| Common Shares | 326 | 325 | 742 | 740 | 739 |
| Retained earnings | -271,180 | -260,312 | -254,272 | -248,345 | -242,091 |
| TOTAL | $67,985 | $77,130 | $20,496 | $26,622 | $32,784 |
| Total Liabilities And Equity | $73,652 | $80,928 | $24,090 | $30,956 | $39,452 |